June Sherie Almenoff - Nov 12, 2024 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Donald R. Reynolds, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Nov 12, 2024
Transactions value $
$12,750
Form type
4
Date filed
11/14/2024, 05:21 PM
Previous filing
Nov 5, 2024
Next filing
Dec 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $6.25K +500 $12.50 500 Nov 12, 2024 By Meadowlark Management, LLC F1, F2
transaction AVTX Common Stock Purchase $6.5K +500 +100% $13.00 1K Nov 13, 2024 By Meadowlark Management, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $12.00 to $12.50. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder full information regarding the number of shares and prices at which the transactions were effected.
F2 The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.